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Low-frequency electroacupuncture
suppresses focal epilepsy and improves
epilepsy-induced sleep disruptions
Pei-Lu YiPhD1,2, Chin-Yu LuMSc1, Shuo-Bin Jou, MD3* and Fang-Chia ChangPhD1,4,5*
Abstract
Background: The positive effects of acupuncture at Feng-Chi acupoints on treating epilepsy and insomnia have
been well-documented in ancient Chinese literature. However, there is a lack of scientific evidence to elucidate
the underlying mechanisms behind these effects. Our previous study demonstrated that high-frequency (100 Hz)
electroacupuncture (EA) at Feng-Chi acupoints deteriorates both pilocarpine-induced focal epilepsy and
sleep disruptions. This study investigated the effects of low-frequency (10 Hz) EA on epileptic activities and
epilepsy-induced sleep disruptions.
Results: In rats, the Feng-Chi acupoint is located 3 mm away from the center of a line between the two ears.
Rats received 30 min of 10 Hz EA stimuli per day before each day’s dark period for three consecutive days.
Our results indicated that administration of pilocarpine into the left CeA at the beginning of the dark period
induced focal epilepsy and decreased both rapid eye movement (REM) sleep and non-REM (NREM) sleep during
the consequent light period. Low-frequency (10 Hz) EA at Feng-Chi acupoints suppressed pilocarpine-induced
epileptiform EEGs, and this effect was in turn blocked by naloxone (a broad-spectrum opioid receptor antagonist), but
not by naloxonazine (a μ-receptor antagonist), naltrindole (a δ-receptor antagonist) and nor-binaltorphimine (a κ-receptor
antagonist). Ten Hz EA enhanced NREM sleep during the dark period, and this enhancement was blocked by all of the
opioid receptor antagonists. On the other hand, 10 Hz EA reversed pilocarpine-induced NREM suppression during the
light period, and the EA’s effect on the sleep disruption was only blocked by naloxonazine.
Conclusions: These results indicate that low-frequency EA stimulation of Feng-Chi acupoints is beneficial in improving
epilepsy and epilepsy-induced sleep disruptions, and that opioid receptors in the CeA mediate EA’s therapeutic effects.
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Background
Epilepsy is one of the most common and devastating
neurological disorders. Seventy percent of epilepsy pa-
tients can be controlled by current anti-epileptic drugs
(AEDs); however, seizures recur in 30 % of patients who
do not respond to any of the first-line AEDs despite
administration of the optimized dosage [1]. Epilepsy pa-
tients experience more daytime somnolence than that of
control patients [2], and children with epilepsy may
suffer from poor quality of sleep, anxiety about sleep
and sleep-disordered breathing [3]. Our previous studies
have demonstrated that epilepsy occurring at different
zeitgeber times results in different sleep disruptions by
altering either the homeostatic factors or circadian
rhythm of the sleep regulations in rats [4, 5]. Sleep
disturbance notably deteriorates and worsens the pro-
gression of epilepsy [6]. Therefore, if a therapy both sup-
presses epilepsy and improves sleep disruptions, it
becomes the optimal therapy for seizure control. Several
alternative therapies, such as vagus nerve stimulation
(VNS) [7, 8] and deep brain stimulation (DBS) [9], have
been considered for treating refractory epilepsy. Our
previous study elucidated that electrical stimulation of
the left anterior thalamic nucleus with a high-frequency
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and low-intensity current reduces the rate of pilocarpine-
induced epilepsy in rats [9]. Acupuncture is another option
for seizure suppression. Indications of acupuncture of the
Feng-Chi (GB20) acupoints have been documented in the
ancient Chinese literature Lingshu Jing (Classic of the
Miraculous Pivot) for its use in suppressing epilepsy and
treating insomnia. Acupuncture may suppress seizures [10,
11] and improve insomnia [12, 13] through the activation
of vagus nerve, which subsequently activates the nucleus of
the tractus solitaries (NTS) and projects rostrally to the
hypothalamus, amygdala, dorsal raphe nucleus, nucleus
ambiguus, parabrachial nucleus, and thalamus [14–20].
Our previous studies demonstrated that the administra-
tion of pilocarpine into the left central nucleus of amygdala
(CeA) induces focal epilepsy [21]. High-frequency (100 Hz)
EA stimuli of the bilateral Feng-Chi acupoints, in which a
30-min EA stimulation was performed prior to the dark
period of the light-dark cycle three consecutive days before
the administration of pilocarpine, did not suppress the
pilocarpine-induced epileptiform electroencephalograms
(EEGs); rather, it further increased the duration of epilepti-
form EEGs in rats [21]. Pilocarpine-induced epilepsy fur-
ther decreases both rapid eye movement (REM) sleep and
non-REM (NREM) sleep [22]. High-frequency EA stimuli
of Feng-Chi acupoints deteriorate pilocarpine-induced sleep
reduction [22]. These results suggest that high-frequency
EA stimuli of Feng-Chi acupoints exhibit no benefit in pro-
tecting against pilocarpine-induced epilepsy and sleep dis-
ruptions. It has been demonstrated that high frequency
stimulation of the vagus nerve causes desynchronized EEG
activity in the cortex and blocks sleep spindles during slow
wave sleep (SWS) [23, 24]. Stimulation of the NTS at low
frequencies (1-16 Hz) produces EEG synchronization,
whereas high frequency (>30 Hz) stimulation results in
EEG desynchronization [25]. In accordance with the afore-
mentioned observations and our results that showed that
different frequencies of EA stimulation on the same acu-
point activate different neural mechanisms [12, 13], we hy-
pothesized that low frequency (10 Hz) EA stimulation
possesses different mechanisms than that of high frequency
(100 Hz) EA and exhibits effects in epilepsy suppression
and the improvement of epilepsy-induced sleep distur-
bances. The amygdala receives the afferent projection from
the NTS [17, 26]. Altering the NTS activity changes the
dynorphin gene expression in the amygdala [27]. It has
been demonstrated that intracerebroventricular (ICV) ad-
ministration of dynorphin suppresses electroconvulsive
shock- and kindling-induced seizure [28, 29]. The temporal
lobe epilepsy increases opioid receptors in the temporal
cortex in humans [30], which may mediate the anticonvul-
sant effects to limit the spread of electrical activity from
other temporal lobe structures [29, 31]. Based upon these
observations, we further proposed that stimulation of Feng-
Chi acupoints activates the vagus nerve and NTS, which
subsequently modulate the opioid receptors in the amyg-
dala to achieve its effects in suppressing focal epilepsy and
blocking epilepsy-induced sleep disruptions.
Methods
Pharmacological agents
Stock solutions of a broad-spectrum opioid antagonist
(naloxone hydrochloride (Tocris, Bristol, UK)), a μ-receptor
antagonist (naloxonazine dihydrochloride (Tocris)), a δ-
receptor antagonist (naltrindole hydrochloride (Tocris))
and a κ-receptor antagonist (nor-binaltorphimine dihy-
drochloride (Tocris)) were dissolved in pyrogen-free saline
(PFS). Pilocarpine (1 mg/μl, Sigma-Aldrich, St. Louis, MO,
USA) was also dissolved in PFS. The stock solutions were
stored at 4 °C until use. Our previous results and others
have indicated that the appropriate microinjection dosage
for naloxonazine, naltrindole and nor-binaltorphimine to
selectively block μ-, δ- and κ-opioid receptors, respectively,
without interaction with other opioid receptor subtypes, is
within 20 μg [12, 13, 32, 33]. In the current study, naloxone,
naloxonazine, naltrindole and nor-binaltorphimine were
microinjected at a dose of 10 μg/μl, which according to our
previous studies efficiently exhibits pharmacological block-
ade [12, 13]. The total volume for each injection was 1 μl
and the duration of injection was 3 to 5 min. Our previous
study has demonstrated that microinjection of 1 μl solution
into the CeA does not cause CeA lesion [34].
Animals
Male Sprague-Dawley rats (250 - 300 g; National Labora-
tory Animal Breeding and Research Center, Taiwan) were
used in this study. Rats were anesthetized by intraperitoneal
injection with 50 mg/kg Zoletil® (Virbac, Carros, France),
which contains tiletamine (an NMDA receptor antagonist)
and zolazepam (a tranquilizer). Rats were surgically im-
planted with three EEG screw electrodes as previously de-
scribed [35] as well as a microinjection guide cannulae
directed into the left CeA (AP, 2.8 mm from bregma; ML,
4.2 mm; DV, 7.8 mm relative to bregma). The coordinates
were adopted from the Paxinos and Watson rat atlas [36].
Two screw EEG electrodes were placed over the left frontal
and parietal lobes of cortices, and a third EEG electrode
was placed over the right cerebellum and served to ground
the animal to reduce signal artifacts. Insulated leads from
EEG electrodes were routed to a Teflon pedestal (Plastics
One, Roanoke, VA, USA). The Teflon pedestal was then
cemented to the skull with dental acrylic (Tempron, GC
Co., Tokyo, Japan). The incision was treated topically with
polysporin (polymixin B sulfate – bacitracin zinc) and the
animals were allowed to recover for seven days prior to the
initiation of experiments. Rats were housed separately in in-
dividual recording cages in the isolated room, in which the
temperature was maintained at 23 ± 1 °C and the light:dark
(L:D) rhythm was controlled in a 12:12 h cycle (40 Watt x
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4 tubes illumination). Food (5001 rodent diet, LabDiet) and
water were available ad libitum. All procedures performed
in this study were approved by the National Taiwan Univer-
sity Animal Care and Use Committee.
Experimental protocol
On the 2nd postsurgical day, these rats were connected
to the recording apparatus (see below) via a flexible
tether. As such, rats were allowed relatively unrestricted
movement within their own cages. One week after rats
had adapted to the 12:12-h L:D cycle after surgery, 24-h
undisturbed baseline recordings of EEGs and sleep-wake
activity were obtained beginning at dark onset on the 1st
day of recording in rats from all groups. Eight groups of
rats were used in the study as follows. Rats in group 1
(n = 6) received a 30-min 10 Hz EA stimulation of the
bilateral Feng-Chi acupoints per day, beginning 30 min
before the dark period and performed over three con-
secutive days (the EA group). EEGs and sleep-wake ac-
tivities were recorded right after the end of the last
period of EA stimuli and lasted for 24 h. Rats in group 2
(n = 6) were administered with pilocarpine in the left
CeA, and EEGs and sleep-wake activities were recorded
beginning from the dark onset of the L:D cycle (the pilo-
carpine group). In group 3 (n = 6), rats received the same
EA stimulation protocol as those rats in the group 2 and
were respectively administered with PFS and pilocarpine
into the CeA before and after the last period of EA
stimulation (the PFS + EA + pilocarpine group). Rats in
group 4 (n = 6) were used to determine the effects of the
opioid receptor antagonist, naloxone, on the 10 Hz
EA-induced alterations in the epileptiform EEGs and
sleep alterations (the naloxone + EA + pilocarpine group).
Rats in group 5 (n = 6), 6 (n = 6), and 7 (n = 6) were respect-
ively used to depict the effects of the μ-receptor antagonist
(naloxonazine, the naloxonazine + EA+ pilocarpine group),
δ-receptor antagonist (naltrindole, the natrindole +
EA + pilocarpine group) and κ-receptor antagonist
(nor-binaltorphimine, the nor-binaltorphimine + EA +
pilocarpine group) on the 10 Hz EA-induced alter-
ations of the epileptiform EEGs and sleep activities.
Rats in groups 4-7 received a similar protocol to that
of the group 3, except that naloxone (10 μg/μl), nalox-
onazine (10 μg/μl), naltrindole (10 μg/μl) and nor-
binaltorphimine (10 μg/μl) were administered into the
CeA before the last period of EA stimulation in group
4, 5, 6 and 7, respectively. Rats in group 8 (n = 6) had
a similar protocol to that of the group 3, except that
rats received the sham EA stimulation (the sham EA
group, the sham EA stimulation described later).
When 10 Hz EA was given (see later), all rats were
lightly anesthetized with 25 mg/kg of zoletil (half of
the dose which we used for surgery), and would wake up
after 30 to 35 min. A 30-min period of EA stimulation was
administered before the onset of the dark period every
day and was applied in three consecutive days. The
anesthetization was given 30 min prior to the dark period
onset and lasted for 30 min. The 10 Hz EA stimulus was
delivered via the bilateral insertion of stainless needles (32
gauge x 1”, Shanghai Yanglong Medical Articles Co.) on
Feng-Chi (GB20) acupoints at a depth of 2 mm. The stimu-
lus consisted of a train of biphasic pulses (150 μs duration
each) of 10 Hz with intensity of 1 mA, and was delivered
by Functions Electrical Stimulator (Trio 300, I.T.O., Japan).
The location of Feng-Chi acupoints in the rats is anatomic-
ally similar to that in humans. The Feng-Chi acupoints (GB
20) is located in the depression between the upper portion
of m. sternocleidomastoideus and m. trapezius in humans.
In rats, the Feng-Chi acupoint is located 3 mm away from
the center of a line between the two ears [37]. Sham EA
was performed with the stimulation of a non-acupoint lo-
cated at the ventral conjunction between the forelimb and
the trunk as previously described [38]. Rats, anesthetized by
zoletil, received the same electrical stimuli, including the
same intensity and frequency, but the stimulation site was
not the location of any acupoint.
Apparatus and recording
Signals from the EEG electrodes were fed into an ampli-
fier (Colbourn Instruments, Lehigh Valley, PA; model
V75-01). The EEG was amplified (factor of 5,000) and
analog bandpass filtered between 0.1 and 40 Hz
(frequency response: ±3 dB; filter frequency roll off:
12 dB/octave). Gross body movements were detected by
custom-made infrared-based motion detectors (Biobserve
GmbH, Germany), and movement activity was converted
to a voltage output, which was digitized and integrated into
1-s bins. These conditioned signals (EEGs and gross body
movements) were subjected to analog-to-digital conversion
with 16-bit precision at a sampling rate of 128 Hz (NI PCI-
6033E; National Instruments, Austin, TX). The digitized
EEG waveform and integrated values for body movement
were stored as binary computer files pending subsequent
analyses.
Postacquisition determination of the vigilance state
was done by visual scoring of 12-s epochs using custom
software (ICELUS, Mark R. Opp) written in LabView for
Windows (National Instruments). The animal’s behavior
was classified as either NREM sleep, REM sleep or wak-
ing based on previously defined criteria [35]. Briefly,
NREM sleep is characterized by large-amplitude EEG
slow waves, high power density values in the delta fre-
quency band (0.5 – 4.0 Hz), and lack of gross body
movements. During REM sleep, the amplitude of the
EEG is reduced, the predominant EEG power density oc-
curs within the theta frequency (6.0 – 9.0 Hz) and there
are phasic body twitches. During waking, the rats are
generally active. There are protracted body movements.
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The amplitude of the EEG is similar to that observed
during REM sleep, but power density values in the delta
frequency band are generally greater than those in theta
frequency band.
Postacquisition determinations of the onset and the
duration of the EEG seizure occurrence were done by
the visual scoring using AxoScope 10 Software (Molecu-
lar Devices, Sunnyvale, CA, USA). We defined EEG doc-
umented seizures as the visualization of epileptiform
spikes with amplitudes greater than 2 mV appearing in
discharges lasting for at least 30 s [9].
Statistical analyses for experiment protocol
All values acquired from the EEG recordings were pre-
sented as a mean ± SEM for the indicated sample sizes.
Unpaired student t-tests for the duration of epileptiform
EEGs were performed to analyze and compare the differ-
ence between groups. Values acquired from sleep-wake
recordings were also indicated as a mean ± SEM. One-
way ANOVA for the duration of each vigilance state
(NREM sleep, REM sleep, WAKE) was performed, com-
paring the effects of different manipulations between
groups across a certain of time block. If statistically sig-
nificant differences were detected, a Fisher’s post-hoc
comparison was made to determine which values during
experimental conditions deviated from those obtained from
the control condition. An α level of p < 0.05 was considered
to indicate a statistically significant difference.
Results
The effect of 10 Hz EA on pilocarpine-induced focal epilepsy
We determined the effect of 10 Hz EA of the bilateral
Feng-Chi acupoints on the epileptiform EEG activities
induced by pilocarpine. No epileptic activity was re-
corded in the naïve rats without any manipulation
(Fig. 1a & Fig. 2a), whereas administration of pilocarpine
into the CeA induced epileptiform EEG (Fig. 1b & Fig. 2).
We found that 10 Hz EA of bilateral Feng-Chi acupoints
slightly induced epileptiform EEGs in the first hour after
EA stimuli (Fig. 2a), which is consistent with the previous
observation of epileptiform EEGs produced by high-
frequency (100 Hz) EA stimuli [21]. However, 10 Hz EA
stimuli significantly blocked pilocarpine-induced epileptic
EEG activities (Fig. 1c, Fig. 2). The average time epileptic
activities were presented in the PFS + EA + pilocarpine
group was significantly reduced from 23.9 ± 19.1 % ob-
tained after pilocarpine administration to 0.6 ± 0.6 % during
the dark period (p < 0.01), and decreased from 20.2 ±
19.9 % to 2.6 ± 2.6 % during the following light period (p <
0.01; Fig. 2a, b & c). Our previous results have shown that
10 Hz sham EA stimulation did not alter baseline EEGs
[12]. We also observed that 10 Hz sham EA stimuli did not
exhibit effect on pilocarpine-induced epileptiform EEGs
(data not shown).
CeA opioid receptors mediate EA’s effect on epilepsy
Application of naloxone (10 μg) significantly blocked
EA’s suppression effect on pilocarpine-induced epilepti-
form EEGs (Fig. 1d & Fig. 3). The average time epileptic
EEGs were exhibited in the naloxone + EA + pilocarpine
group was significantly enhanced to 5.4 ± 2.5 % during
the dark period (p < 0.01 vs. PFS + EA + pilocarpine
group; Fig. 3b). However, naloxonazine (10 μg), naltrin-
dole (10 μg) and nor-binaltorphimine (10 μg) exhibited
no effect on blocking EA’s effect (Fig. 3).
Effects of administration of pilocarpine into the left CeA
on sleep
Administration of pilocarpine into the CeA at the be-
ginning of the dark period did not significantly change
the amounts of NREM sleep and REM sleep during
the dark period; however, both NREM sleep and REM
sleep were significantly decreased during the following
12-h light period (Fig. 4c & d). The percentage of time
spent in NREM sleep during the light period was de-
creased from 50.5 ± 1.9 % obtained from undisturbed
rats to 33.8 ± 3.2 %, acquired after administration of
pilocarpine (the pilocarpine group) at the dark onset
(p < 0.05, Fig. 4f ). The amount of REM sleep during
the light period was also reduced from 15.3 ± 1.3 % to
8.9 ± 1.0 % (p < 0.05, Fig. 4h). These data are adapted
from our previous observations in order to reduce the
use of animals [22].
Effects of 10 Hz EA stimuli on sleep in naïve and epileptic
rats
There was no significant change in the sleep-wake activ-
ity when rats received sham EA stimuli (the sham EA
group, Fig. 4a), except for sleep suppression of NREM
and REM sleep during the first 4 h of the dark period.
Our previous results have demonstrated that the
anesthetization of rats for 30 min with ketamine, an
NMDA receptor antagonist, prior to the dark period
suppressed both NREM sleep and REM sleep during the
first four hours of the dark period [12, 22]. Therefore,
the decreases of NREM sleep and REM sleep during the
first 4 h of the dark period when rats received the 10 Hz
sham EA stimuli and were under anesthetization were
primarily due to the effect of tiletamine, a composition
of zoletil. In contrast, 10 Hz EA stimuli of Feng-Chi acu-
points over three consecutive days enhanced physio-
logical NREM sleep, but not REM sleep, during the dark
period (the EA group) in the naïve rats. The percentage
of time spent in NREM sleep during the dark period in-
creased from 19.6 ± 1.7 % obtained from undisturbed
rats to 27.3 ± 2.3 % (p < 0.05; Fig. 4). However, both
NREM sleep and REM sleep were decreased in the fol-
lowing light period, which might simply be due to a
compensatory effect. These results suggest that 10 Hz
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EA stimuli of bilateral Feng-Chi acupoints possess a
somnogenic effect.
Rats received a 30-min 10 Hz EA stimulation of bilat-
eral Feng-Chi acupoints over three consecutive days that
blocked pilocarpine-induced NREM sleep reduction, but
not the REM sleep reduction (Fig. 4c, d, f & h). The per-
centage of time spent in NREM sleep during the light
period was enhanced to 45.8 ± 2.3 % (p < 0.05 vs. the
pilocarpine group; Fig. 4f ). Furthermore, 10 Hz EA stim-
uli also increased NREM sleep during the dark period in
the epileptic rats; the time spent in NREM sleep
increased from 16.5 ± 2.3 % obtained after pilocarpine
administration to 37.5 ± 3.2 % (p < 0.05; Fig. 4c & e), al-
though pilocarpine did not change any aspect of NREM
sleep during the dark period.
Effects opioid receptor antagonists on the 10 Hz EA-induced
sleep alteration in epileptic rats
Administration of naloxone significantly blocked the
10 Hz EA-induced enhancement of NREM sleep during
the first 3 h of the dark period in epileptic rats, but ex-





Fig. 1 The effect of 10 Hz EA stimulation of bilateral Feng-Chi acupoints and naloxone on epileptic activities. Panels a, b, c and d respectively
depict the EEG signals recorded from the naïve rats, the pilocarpine group, the PFS + EA + pilocarpine group and the naloxone + EA + pilocarpine
group, beginning from the dark onset of the dark period. Pilocarpine was administered at time 0 in the left panels of b, c and d. The blue boxes
represent the epileptiform EEGs. Red lines indicate the extracted time points for the expanded time-scale figures in the right panels. Green arrowheads
are the artifacts. The larger amplitudes, with EEG signals less than 2 mV that appeared in panels a, were delta waves, which represent the state of slow
wave sleep
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The percentage of time spent in NREM sleep during the
first 3 h of the dark period in the naloxone + EA + pilo-
carpine group was significantly decreased from 39.9 ±
11.0 % obtained from the PFS + EA + pilocarpine group
to 7.08 ± 3.2 % (p < 0.05). REM sleep was not signifi-
cantly altered after administration of naloxone (Fig. 5b
& Fig. 6). Our previous study demonstrates that admin-
istration of naloxone into the CeA does not alter sleep
activity in rats [22], suggesting that the EA-induced en-
hancement of NREM sleep is specifically mediated by
CeA opioid receptors.
Administration of naloxonazine significantly blocked
the 10 Hz EA-induced enhancement of NREM sleep
during the dark period and subsequent light period in
epileptic rats (Fig. 5c, Fig. 6a & b). The percentage of
time spent in NREM sleep during the first 4 h of
the dark period in the naloxonazine + EA + pilocarpine
group was significantly decreased from 39.2 ± 8.3 % ob-
tained from the PFS + EA + pilocarpine group to 11.1 ±
4.5 % (p < 0.05), and that of NREM sleep was reduced
from 45.8 ± 2.3 % to 34.7 ± 2.5 % (p < 0.05) during the
subsequent light period. REM sleep was not signifi-
cantly altered after administration of naloxonazine
(Fig. 5d & Fig. 6).
Administration of naltrindole significantly blocked the
10 Hz EA-induced enhancement of NREM sleep during
the first 3 h of the dark period in epileptic rats, but dem-
onstrated no effect during the light period (Fig. 5e &
Fig. 6). The percentage of time spent in NREM sleep
during the first 3 h of the dark period in the naltindole +
EA + pilocarpine group was significantly decreased to
12.3 ± 3.5 % (p < 0.05 vs. the PFS + EA + pilocarpine
group). REM sleep was not significantly altered after ad-
ministration of naltrindole (Fig. 5f & Fig. 6).
Administration of nor-binaltorphimine significantly
blocked the 10 Hz EA-induced enhancement of NREM
sleep during the first 3 h of the dark period in epileptic
rats, but demonstrated no effect during the light period
(Fig. 5g & Fig. 6). The percentage of time spent in
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Fig. 2 A summary of 10 Hz EA stimulation of bilateral Feng-Chi acupoints on epileptic activities. In panel a, the black circles represent the values
obtained from the naïve group, the black triangles depict the results of the EA group, the white circles demonstrate the values obtained from
the pilocarpine group, and the white triangles indicate the data acquired from the PFS + EA + pilocarpine group. The black and white horizontal
bars represent the 12-h dark and 12-h light period of the 12:12 h light dark cycle. Panel b depicts the results obtained from the dark period and
panel c demonstrates the data acquired from the light period. Bars 1-4 spanning from the left to the right in panels b and c represent the results
obtained from the naïve rats, the EA group, the pilocarpine group, and the PFS + EA + pilocarpine group, respectively. **: p < 0.01 vs. the naïve rats;
#: p < 0.01 vs. the pilocarpine group
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the nor-binaltorphimine + EA + pilocarpine group was
significantly decreased to 12.8 ± 4.3 % (p < 0.05 vs. the
PFS + EA + pilocarpine group). No significant change
occurred in REM sleep after administration of nor-binal-
torphimine (Fig. 5H & Fig. 6).
Discussion
Systemic or intracerebral administration of high-dose
pilocarpine, a cholinergic muscarinic agonist, establishes
the animal model of temporal lobe epilepsy and status
epilepticus in rodents [39]. Several brain regions (e.g. the
amygdala, thalamus, olfactory cortex, hippocampus, neo-
cortex, and substantial nigra) are affected after pilocarpine
administration [40]. As a matter of fact, the amygdala is the
key brain structure that elicits epilepsy after administration
of pilocarpine in rats or mice. Microinjection of bethane-
chol, a potent muscarinic agonist that is resistant to acetyl-
cholinesterases, into the amygdala results in epileptiform
EEGs, and the epileptic activities subsequently spread to
the hippocampus and cortex [40]. Clinical and experimen-
tal evidence indicates that epilepsy and sleep reciprocally
influence each other. It has been noticed that patients with
different types of epilepsy experience different sleep disrup-
tions. Patients with temporal lobe epilepsy (TLE) often
encounter sleep fragmentation with a decrease in sleep effi-
ciency, whereas patients with frontal lobe epilepsy (FLE)
show little change in classical sleep parameters [41]. How-
ever, analysis of the microstructures of sleep in nocturnal
FLE patients demonstrates sleep instability and arousal fluc-
tuations [42]. In animal studies, we further elucidated that
the occurrence of epilepsy at different zeitgeber time results
in different sleep disturbances by altering either the homeo-
static factors or the circadian rhythm of sleep-wake regula-
tion [4, 5]. NREM sleep promotes seizure discharge [43],
whereas REM sleep decreases seizure susceptibility [44].
Therefore, if a therapy can accomplish both epilepsy
suppression and the improvement of sleep disturb-
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Fig. 3 The summary of the effects of naloxone, naloxonazine, naltrindole and nor-binaltorphimine on the 10 Hz EA-induced suppression of
epileptic activity. In panel a, the black circles represent the values obtained from the PFS + EA + pilocarpine group, the black triangles depict the
results of the naloxone + EA + pilocarpine group, the white circles demonstrate the values obtained from the naloxonazine + EA + pilocarpine group,
the white diamonds elucidate the results of the naltrindole + EA + pilocarpine group, and the white triangles indicate the data acquired from the
nor-binaltorphimine + EA + pilocarpine group. Panel b depicts the results obtained from the dark period and panel C demonstrates the data
acquired from the light period. Bars 1-5 spanning from the left to the right in panels b and c represent the results obtained from the PFS + EA +
pilocarpine group, naloxone + EA + pilocarpine group, naloxonazine + EA + pilocarpine group, naltrindole + EA + pilocarpine group and
nor-binaltorphimine + EA + pilocarpine group, respectively.**: p < 0.01 vs. the PFS + EA + pilocarpine group
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EA stimulation of bilateral Feng-Chi acupoints may
become a potential therapy to suppress epileptic activ-
ity and improve epilepsy-induced sleep disruptions.
Although lacking scientific evidence, Lingshu Jing, an
ancient Chinese literature, documents these indications of
epilepsy suppression and insomnia treatment. The purpose
of current study was therefore focused on the effect of
10 Hz EA stimuli of Feng-Chi acupoints on focal epilepsy,
and the sleep disruptions in epileptic rats induced by ad-








Fig. 4 The effects of 10 Hz EA stimulation and pilocarpine in sleep. Panels a & b: NREM sleep and REM sleep obtained from the undisturbed
baseline (naïve rats), the sham EA group and the EA group. Panels c & d: NREM sleep and REM sleep acquired from the baseline, the pilocarpine
group and the PFS + EA + pilocarpine group. Black circles: the values obtained from undisturbed rats (baseline); black triangles: the values obtained from the
sham EA group; open diamonds: the values acquired from the EA group; open circles: the values obtained from the pilocarpine group; open triangles: the
data acquired from the PFS + EA + pilocarpine group. *: p < 0.05 vs. baseline. Black bar: the dark period; white bar: the light period. The bars from the left to
the right in panels E-H represent the data acquired from the baseline, the EA group, the pilocarpine group and the PFS + EA + pilocarpine group. Panels e
and f represent the percentage of time spent in NREM sleep during the 12-h dark period and the subsequent 12-h light period, respectively. Panels g and
h indicate the percentage of time spent in REM sleep during the 12-h dark period and the subsequent 12-h light period, respectively. All symbols represent
a significance with a p < 0.05 when comparing between two groups
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previous study had validated that the microinjection of low
dose (1 mg/μl) pilocarpine into the left CeA induces focal
epilepsy in rats. EEG signals were acquired from the left
and right frontal, parietal and occipital cortices using mul-
tiple electrodes [21], and we confirmed this model again in
current study. Our results indicated that no sleep param-
eter was altered during the dark period, but both NREM
sleep and REM sleep were decreased in the following light
period when pilocarpine was administered at the beginning
of the dark period.
We examined the effect of 10 Hz EA stimuli of bilat-
eral Feng-Chi acupoints in naïve rats and found that low
frequency EA slightly induced epileptiform EEGs during










Fig. 5 Naloxone, naloxonazine, naltrindole and nor-binaltorphimine on EA’s effect on sleep in rats with focal epilepsy. Panels a & b: the effects
of naloxone on NREM sleep and REM sleep. Panels c & d: the effects of naloxonazine on NREM sleep and REM sleep. Panels e & f: the effects
of naltrindole on NREM sleep and REM sleep. Panels g & h: the effects of nor-binaltorphimine on NREM sleep and REM sleep. Black circles: the
data obtained from the PFS + EA + pilocarpine group; black triangles: the values acquired from the naloxone + EA + pilocarpine group; open circles:
the results obtained from the naloxonazine + EA + pilocarpine group; open diamonds: the data acquired from the naltrindole + EA + pilocarpine
group; open triangles: the values obtained from the nor-binaltorphimine + EA + pilocarpine group. *: p < 0.05 when comparing the values between
two groups
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consistent with our previous results with high frequency
(100 Hz) EA stimuli of Feng-Chi [21]. The reason for
this induction of epileptic activities after EA stimuli of
Feng-Chi acupoints might be due to the nonspecific
stimulation of the brainstem and raising EEG activities.
Application of 10 Hz EA stimuli of Feng-Chi acupoints
significantly suppressed pilocarpine-induced epileptiform
EEGs, which differs from both the result of 10 Hz EA in
naïve rats and the exacerbation effect of 100 Hz EA on
epileptic activities [21]. Furthermore, 10 Hz of EA stim-
uli of Feng-Chi acupoints in naïve rats enhanced NREM
sleep during the dark period, but decreased both NREM
sleep and REM sleep in the subsequent light period. This
observation differs from our previous finding that dem-
onstrates 100 Hz EA stimuli of Feng-Chi acupoints ex-
hibits no effect on physiological sleep in naïve rats [22].
This suggests that 10 Hz, but not 100 Hz, of EA stimuli
of Feng-Chi acupoints promotes sleep. The decreases of
NREM sleep and REM sleep in the subsequent light
period might simply be due to the compensatory effect
to counter the enhancement of NREM sleep during the
dark period. We further found that the epilepsy-induced
reduction of NREM sleep during the light period was
blocked by 10 Hz EA of Feng-Chi acupoints. This result
indicates that the effect of 10 Hz EA on the blockade of
epilepsy-induced sleep reduction during the light period
is mediated by a specific mechanism, since it exhibited
an opposite action when 10 Hz EA was applied in the
naïve rats. Based upon previous studies, we had hypoth-
esized that EA of Feng-Chi acupoints stimulates vagus
nerves and subsequently activates NTS [12, 13, 21, 22].
It is worthy to note from our current and past studies
that different stimulation parameters of EA result in differ-
ent outcomes in the regulations of EEG activity and sleep
states. Consistent with the observations of EA stimuli,
different parameters of the VNS can either induce elec-
trographic synchronization or desynchronization. High-
frequency dominant EEGs appear after cats received
VNS with frequencies between 24-50 Hz [23]. Chase et
al. have also demonstrated that desynchronized EEGs can
be induced by lower frequency VNS (20 Hz), whereas
high frequency (200 Hz) stimulation of vagus nerve
causes EEG synchronization [45]. Fifty Hz VNS desynchro-
nizes EEGs and blocks sleep spindles [24]. VNS increases
both NREM sleep and REM sleep in the “encephale isole”
cats [46], and enhances ponto-geniculate-occipital (PGO)
wave density and the total amount of REM sleep in normal
cats [47]. This might be because the vagus nerves contain
A-, B- and C-fibers, which have different thresholds for




Fig. 6 The summary of naloxone, naloxonazine, naltrindole and nor-binaltorphimine on EA’s effect on sleep in rats with focal epilepsy. The bars
from the left to the right in each panel represent the data acquired from the PFS + EA + pilocarpine group, the naloxone + EA + pilocarpine group,
the naloxonazine + EA + pilocarpine group, the naltrindole + EA + pilocarpine and the nor-binaltorphimine + EA + pilocarpine group. Panels a and b
represent the percentage of time spent in NREM sleep during the 12-h dark period and the subsequent 12-h light period, respectively. Panels c
and d indicate the percentage of time spent in REM sleep during the 12-h dark period and the subsequent 12-h light period, respectively. **: p <
0.05 when comparing the values between two groups
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therapeutic parameters for VNS are frequencies of 20-
30 Hz with intensities of 0.5-3.5 mA; however, irreversible
damage of the vagus nerve is caused by a stimulation
frequency higher than 50 Hz [48]. Nevertheless, our
current results depicted that 10 Hz EA of Feng-Chi
acupoints can successfully suppress the epileptiform
EEGs induced by pilocarpine and block pilocarpine-
induced reduction of NREM sleep, which differs from
the outcomes of 100 Hz EA on the exacerbation of
both epilepsy and epilepsy-induced sleep disruptions
[21, 22]. The choice of frequency for EA stimulation is
an important issue in order to exert a therapeutic
effect.
Endogenous opioid peptides (e.g., encephalin, β-
endorphin, dynorphin and endormorphin) and their
receptors (such as μ-, δ- and κ-opioid receptors) medi-
ate most of the effects of acupuncture, especially in
acupuncture-induced analgesia. Han and his col-
leagues have revealed that low-frequency (2 Hz) EA
stimuli increase met-enkephalin, but not dynorphin, in
the spinal cord, while high-frequency (100 HZ) EA
stimuli increase the release of dynorphin rather than
that of met-enkephalin [49]. We have previously dem-
onstrated that μ-receptors in the NTS mediate the
sleep enhancements induced by low-frequency (10 Hz)
EA stimulation of bilateral Anmian acupoints, whereas
the activation of κ-receptors contributes to the high-
frequency (100 Hz) EA-induced sleep increases [12,
13]. Because the amygdala is the epileptic focus in the
current animal model and plays an important role in
the sleep regulation [50], we herein investigated the
role of CeA opioid receptors. We found that the ad-
ministration of naloxone, but not other specific opioid
receptor antagonists, into the CeA blocked the effect
of EA on epilepsy suppression, indicating the involve-
ment of all types of opioid receptors. This finding is
consistent with the results that indicate naloxone
blocks the morphine-induced anticonvulsant effect
[51]. Our results also demonstrated that the micro-
injection of naloxonazine into the CeA significantly
blocks 10 Hz EA stimulation-induced NREM sleep
disruption during the light period in rats with focal
epilepsy, suggesting the role of μ-opioid receptors in
the effects of 10 Hz EA stimulation. Furthermore, the
NREM sleep enhancement induced by 10 Hz EA dur-
ing the dark period in epileptic rats was also blocked
by naloxone, naloxonazine, naltrindole and nor-binal-
torphimine. Since pilocarpine did not alter NREM
sleep during the dark period and the administration of
naloxone into CeA exhibited no effect on sleep param-
eters in naïve rats [22], this blockade effect by opioid
receptor antagonists is primarily due to the specific
action of CeA opioid receptors on the EA-induced
sleep.
Conclusions
Our current results indicated that low-frequency (10 Hz)
EA stimulation of bilateral Feng-Chi acupoints success-
fully suppresses pilocarpine-induced focal epilepsy and
blocks sleep disruption in epileptic rats. Our current
study also demonstrated the involvement of CeA opioid
receptors in mediating the effects of EA stimulation.
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